These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6222065)

  • 21. Activity of spectinomycin against anaerobes.
    Rosenblatt JE; Gerdts AM
    Antimicrob Agents Chemother; 1977 Jul; 12(1):37-9. PubMed ID: 18985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative susceptibility patterns of common clinical isolates to cefoperazone: 1981 to 1987.
    Jenkins SG
    Am J Med; 1988 Jul; 85(1A):52-5. PubMed ID: 3135749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of in vitro methods for testing ceftriaxone against anaerobic bacteria, including quality control guidelines.
    Barry AL; Jones RN
    J Clin Microbiol; 1988 Apr; 26(4):776-7. PubMed ID: 2896669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
    Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibacterial activity of cefoperazone against anaerobic bacteria (author's transl)].
    Imamura H; Kobayashi T; Murata K; Kohbata S; Watanabe I; Marui T; Watanabe K; Ninomiya K; Ueno K; Suzuki S
    Jpn J Antibiot; 1980 Nov; 33(11):1171-82. PubMed ID: 6454011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.
    Rolfe RD; Finegold SM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):600-9. PubMed ID: 7325628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone.
    Thornsberry C; Barry AL; Jones RN; Baker CN; Badal RE
    J Clin Microbiol; 1982 May; 15(5):769-76. PubMed ID: 6212595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefoperazone: regression analysis, disk content, and disk susceptibility testing considerations.
    Wright DN; Welch DF; Saxon BA; Clark SJ; Matsen JM
    Antimicrob Agents Chemother; 1982 Sep; 22(3):493-8. PubMed ID: 6215895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative activity of several beta-lactam antibiotics against anaerobes determined by two methods.
    Zabransky RJ; Birk RJ
    Clin Ther; 1987; 10(1):107-25. PubMed ID: 3450391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.
    Jorgensen JH; Crawford SA; Alexander GA
    Antimicrob Agents Chemother; 1980 May; 17(5):901-4. PubMed ID: 6249198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefoperazone and cefotiam--two new cephalosporins: an in-vitro comparison.
    Wise R; Andrews JM; Bedford KA
    J Antimicrob Chemother; 1981 Apr; 7(4):343-52. PubMed ID: 6454675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of cefaclor against aerobic and anaerobic bacteria.
    Bach VT; Khurana MM; Thadepalli H
    Antimicrob Agents Chemother; 1978 Feb; 13(2):210-3. PubMed ID: 646343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
    Lang SD; Edwards DJ; Durack DT
    Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro activity of ceftizoxime against anaerobic bacteria and comparison with other cephalosporins.
    Chow AW; Finegold SM
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():45-50. PubMed ID: 6296028
    [No Abstract]   [Full Text] [Related]  

  • 36. Cefoperazone: spectrum of antibacterial activity and disc diffusion testing.
    Thornsberry C; Jones RN
    Drugs; 1981; 22 Suppl 1():3-12. PubMed ID: 6456889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro antibacterial activity of cefoperazone, a piperazine cephalosporin.
    King A; Warren C; Shannon K; Phillips I
    J Antimicrob Chemother; 1981 Aug; 8(2):107-13. PubMed ID: 6456255
    [No Abstract]   [Full Text] [Related]  

  • 38. Activity of cefoperazone against ampicillin-resistant bacteria in agar and broth dilution tests.
    Kayser FH; Morenzoni G; Homberger F
    Antimicrob Agents Chemother; 1982 Jul; 22(1):15-22. PubMed ID: 6214994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of anaerobes to cefoxitin and other cephalosporins.
    Tally FP; Jacobus NV; Bartlett JG; Gorbach SL
    Antimicrob Agents Chemother; 1975 Feb; 7(2):128-32. PubMed ID: 1137364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    Antimicrob Agents Chemother; 1985 May; 27(5):679-82. PubMed ID: 3893316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.